Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

financial strength, statements regarding the potential of our first–in–class clinical programs and pharma partnerships; statements regarding the potential of our differentiated computational discovery engine; and statements regarding our ability to convert these opportunities into long-term value for patients and shareholders. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance, or achievements of Compugen to be materially differe ...